Another series looking at EGFR and HER2 expression in human bladder cancer specimens found EGFR expression in up to 72.2% of tumors and HER2 expression in 44.5% of tumors, with 33.9% of tumors co-expressing both13. Here, ERBB2 is linked to urinary bladder cancer.